» Articles » PMID: 22678893

Cyclic AMP Underpins Suppression by Regulatory T Cells

Overview
Journal Eur J Immunol
Date 2012 Jun 9
PMID 22678893
Citations 42
Authors
Affiliations
Soon will be listed here.
Abstract

Elevated levels of intracellular cyclic adenosine monophosphate (cAMP) in naturally occurring T regulatory (nTreg) cells play a key role in nTreg-cell-mediated suppression. Upon contact with nTreg cells, cAMP is transferred from nTreg cells into activated target CD4(+) T cells and/or antigen-presenting cells (APCs) via gap junctions to suppress CD4(+) T-cell function. cAMP facilitates the expression and nuclear function of a potent transcriptional inhibitor, inducible cAMP early repressor (ICER), resulting in ICER-mediated suppression of interleukin-2 (IL-2). Furthermore, ICER inhibits transcription of nuclear factor of activated T cell c1/α (NFATc1/α) and forms inhibitory complexes with preexisting NFATc1/c2, thereby inhibiting NFAT-driven transcription, including that of IL-2. In addition to its suppressive effects mediated via ICER, cAMP can also modulate the levels of surface-expressed cytotoxic T lymphocyte antigen-4 (CTLA-4) and its cognate B7 ligands on conventional CD4(+) T cells and/or APCs, fine-tuning suppression. These cAMP-driven nTreg-cell suppression mechanisms are the focus of this review.

Citing Articles

Phosphodiesterases 4B and 4D Differentially Regulate cAMP Signaling in Calcium Handling Microdomains of Mouse Hearts.

Kraft A, Bork N, Subramanian H, Pavlaki N, Failla A, Zobiak B Cells. 2024; 13(6.

PMID: 38534320 PMC: 10969065. DOI: 10.3390/cells13060476.


Regulatory T Cells for Control of Autoimmunity.

Kawakami R, Sakaguchi S Adv Exp Med Biol. 2024; 1444:67-82.

PMID: 38467973 DOI: 10.1007/978-981-99-9781-7_5.


Mechanisms underlying immunosuppression by regulatory cells.

Goldmann O, Nwofor O, Chen Q, Medina E Front Immunol. 2024; 15:1328193.

PMID: 38380317 PMC: 10876998. DOI: 10.3389/fimmu.2024.1328193.


cAMP-PKA/EPAC signaling and cancer: the interplay in tumor microenvironment.

Zhang H, Liu Y, Liu J, Chen J, Wang J, Hua H J Hematol Oncol. 2024; 17(1):5.

PMID: 38233872 PMC: 10792844. DOI: 10.1186/s13045-024-01524-x.


Soluble adenylyl cyclase contributes to imiquimod-mediated inflammation and is a potential therapeutic target in psoriasis.

You J, Reilly M, Eljalby M, Bareja R, Yusupova M, Vyas N Exp Dermatol. 2023; 32(7):1051-1062.

PMID: 37039485 PMC: 10523866. DOI: 10.1111/exd.14811.